This inventor holds 1 USPTO granted patent. Top assignees: Hanmi Pharmaceutical Co., Ltd., Spectrum Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
1 out of 8 
1 out of 38 
Years Active: 2024
Title: Kweehyun Suh: Innovator in Quinazoline Compounds
Introduction
Kweehyun Suh is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of chemistry, particularly in the development of quinazoline compounds. His work has implications in various pharmaceutical applications.
Latest Patents
Kweehyun Suh holds a patent for "Crystalline forms of a quinazoline compound and its hydrochloride salts." This patent document details the crystalline forms of a specific quinazoline compound and its hydrochloride salts. The preparation method described in the patent focuses on 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one and its hydrochloride salts.
Career Highlights
Throughout his career, Kweehyun Suh has worked with prominent companies in the pharmaceutical industry. He has been associated with Hanmi Pharmaceutical Co., Ltd. and Spectrum Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Kweehyun Suh has collaborated with notable colleagues, including Jong Ouk Baek and Hee Cheol Kim. These partnerships have likely enhanced his research and development efforts in the field of pharmaceuticals.
Conclusion
Kweehyun Suh is a distinguished inventor whose work on quinazoline compounds has the potential to impact the pharmaceutical industry significantly. His contributions through patents and collaborations reflect his commitment to innovation in chemistry.